Senti Biosciences Statistics
Total Valuation
SNTI has a market cap or net worth of $9.71 million. The enterprise value is $33.94 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, after market close.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SNTI has 4.58 million shares outstanding. The number of shares has increased by 2.86% in one year.
| Current Share Class | 4.58M |
| Shares Outstanding | 4.58M |
| Shares Change (YoY) | +2.86% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 8.17% |
| Owned by Institutions (%) | 8.10% |
| Float | 2.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.61 |
| P/TBV Ratio | 0.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.92, with a Debt / Equity ratio of 2.17.
| Current Ratio | 1.92 |
| Quick Ratio | 1.29 |
| Debt / Equity | 2.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -143.27% and return on invested capital (ROIC) is -41.57%.
| Return on Equity (ROE) | -143.27% |
| Return on Assets (ROA) | -37.51% |
| Return on Capital (ROIC) | -41.57% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.48M |
| Employee Count | 48 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.33% in the last 52 weeks. The beta is 2.75, so SNTI's price volatility has been higher than the market average.
| Beta (5Y) | 2.75 |
| 52-Week Price Change | -47.33% |
| 50-Day Moving Average | 2.37 |
| 200-Day Moving Average | 3.02 |
| Relative Strength Index (RSI) | 44.31 |
| Average Volume (20 Days) | 17,659 |
Short Selling Information
The latest short interest is 65,095, so 1.42% of the outstanding shares have been sold short.
| Short Interest | 65,095 |
| Short Previous Month | 59,182 |
| Short % of Shares Out | 1.42% |
| Short % of Float | 2.23% |
| Short Ratio (days to cover) | 3.27 |
Income Statement
| Revenue | n/a |
| Gross Profit | -9.12M |
| Operating Income | -56.86M |
| Pretax Income | -64.45M |
| Net Income | -70.90M |
| EBITDA | -52.96M |
| EBIT | -56.86M |
| Earnings Per Share (EPS) | -$15.59 |
Full Income StatementBalance Sheet
The company has $10.48 million in cash and $34.71 million in debt, giving a net cash position of -$24.23 million or -$5.29 per share.
| Cash & Cash Equivalents | 10.48M |
| Total Debt | 34.71M |
| Net Cash | -24.23M |
| Net Cash Per Share | -$5.29 |
| Equity (Book Value) | 15.99M |
| Book Value Per Share | 3.49 |
| Working Capital | 8.32M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$34.93 million and capital expenditures -$19,000, giving a free cash flow of -$34.95 million.
| Operating Cash Flow | -34.93M |
| Capital Expenditures | -19,000 |
| Free Cash Flow | -34.95M |
| FCF Per Share | -$7.63 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -4,173.65% |